Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacyMarit J van Elsas, Sjoerd H. van der Burg|Cancer Cell|2024Cited by 133
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapyMarit J van Elsas, Sjoerd H. van der Burg|Journal for ImmunoTherapy of Cancer|2023Cited by 35